Immunization Safety Review

Immunization Safety Review
Author: Institute of Medicine
Publisher: National Academies Press
Total Pages: 118
Release: 2003-11-26
Genre: Medical
ISBN: 0309168910

The Immunization Safety Review Committee was established by the Institute of Medicine (IOM) to evaluate the evidence on possible causal associations between immunizations and certain adverse outcomes, and to then present conclusions and recommendations. The committee's mandate also includes assessing the broader societal significance of these immunization safety issues. While all the committee members share the view that immunization is generally beneficial, none of them has a vested interest in the specific immunization safety issues that come before the group. The committee reviews three immunization safety review topics each year, addressing each one at a time. In this fifth report in a series, the committee examines the hypothesis that exposure to polio vaccine contaminated with simian virus 40 (SV40), a virus that causes inapparent infection in some monkeys, can cause certain types of cancer.

Rubella Viruses

Rubella Viruses
Author: Jangu Banatvala
Publisher: Elsevier
Total Pages: 139
Release: 2006-12-18
Genre: Science
ISBN: 0080467865

This latest volume provides a comprehensive review of the latest developments and research studies on the pathogenesis and molecular biology of human congenital infections. It reviews current diagnostic techniques and epidemiological data while describing the progress in research and understanding of continuing prevention of congenital infections and prognosis.

Adverse Effects of Vaccines

Adverse Effects of Vaccines
Author: Institute of Medicine
Publisher: National Academies Press
Total Pages: 894
Release: 2012-04-26
Genre: Medical
ISBN: 0309214351

In 1900, for every 1,000 babies born in the United States, 100 would die before their first birthday, often due to infectious diseases. Today, vaccines exist for many viral and bacterial diseases. The National Childhood Vaccine Injury Act, passed in 1986, was intended to bolster vaccine research and development through the federal coordination of vaccine initiatives and to provide relief to vaccine manufacturers facing financial burdens. The legislation also intended to address concerns about the safety of vaccines by instituting a compensation program, setting up a passive surveillance system for vaccine adverse events, and by providing information to consumers. A key component of the legislation required the U.S. Department of Health and Human Services to collaborate with the Institute of Medicine to assess concerns about the safety of vaccines and potential adverse events, especially in children. Adverse Effects of Vaccines reviews the epidemiological, clinical, and biological evidence regarding adverse health events associated with specific vaccines covered by the National Vaccine Injury Compensation Program (VICP), including the varicella zoster vaccine, influenza vaccines, the hepatitis B vaccine, and the human papillomavirus vaccine, among others. For each possible adverse event, the report reviews peer-reviewed primary studies, summarizes their findings, and evaluates the epidemiological, clinical, and biological evidence. It finds that while no vaccine is 100 percent safe, very few adverse events are shown to be caused by vaccines. In addition, the evidence shows that vaccines do not cause several conditions. For example, the MMR vaccine is not associated with autism or childhood diabetes. Also, the DTaP vaccine is not associated with diabetes and the influenza vaccine given as a shot does not exacerbate asthma. Adverse Effects of Vaccines will be of special interest to the National Vaccine Program Office, the VICP, the Centers for Disease Control and Prevention, vaccine safety researchers and manufacturers, parents, caregivers, and health professionals in the private and public sectors.

Field Guidelines for Surveillance of Measles, Rubella and Congenital Rubella Syndrome

Field Guidelines for Surveillance of Measles, Rubella and Congenital Rubella Syndrome
Author: WHO Regional Office for the Eastern Mediterranean
Publisher:
Total Pages: 0
Release: 2011
Genre: Medical
ISBN: 9789290217428

These field guidelines provide countries with a technical resource to use in developing comprehensive standard operating procedures for measles, rubella and congenital rubella syndrome surveillance. The largest part of these guidelines is devoted to developing a surveillance system for cases of measles, rubella and congenital rubella syndrome, including case investigation, outbreak response, laboratory procedures for measles and rubella testing and surveillance monitoring and feedback. This publication is primarily intended for use by surveillance and national immunization managers and their staff, but many other health professionals and technical staff working in surveillance, immunization and laboratories at the country level will find it useful in improving measles, rubella and congenital rubella syndrome surveillance. It can be used at various levels of the health care system and countries can adapt the guidelines according to their local situations.

Field Guidelines for Surveillance of Measles, Rubella and Congenital Rubella Syndrome

Field Guidelines for Surveillance of Measles, Rubella and Congenital Rubella Syndrome
Author:
Publisher:
Total Pages: 51
Release: 2011
Genre: Measles
ISBN: 9789290217435

"These field guidelines provide countries with a technical resource to use in developing comprehensive standard operating procedures for measles, rubella and congenital rubella syndrome surveillance. The largest part of these guidelines is devoted to developing a surveillance system for cases of measles, rubella and congenital rubella syndrome, including case investigation, outbreak response, laboratory procedures for measles and rubella testing and surveillance monitoring and feedback. This publication is primarily intended for use by surveillance and national immunization managers and their staff, but many other health professionals and technical staff working in surveillance, immunization and laboratories at the country level will find it useful in improving measles, rubella and congenital rubella syndrome surveillance. It can be used at various levels of the health care system and countries can adapt the guidelines according to their local situations"--Back cover.

Canadian Immunization Guide

Canadian Immunization Guide
Author: Canada. Comité consultatif national de l'immunisation
Publisher:
Total Pages: 392
Release: 2006
Genre: Immunization
ISBN: 9780660193922

The seventh edition of the Canadian Immunization Guide was developed by the National Advisory Committee on Immunization (NACI), with the support ofthe Immunization and Respiratory Infections Division, Public Health Agency of Canada, to provide updated information and recommendations on the use of vaccines in Canada. The Public Health Agency of Canada conducted a survey in 2004, which confi rmed that the Canadian Immunization Guide is a very useful and reliable resource of information on immunization.

Immunization in Practice

Immunization in Practice
Author:
Publisher: World Health Organization
Total Pages: 292
Release: 2015
Genre: Medical
ISBN: 9241549092

This practical guide contains seven modules targeted at district and health facility staff. It intends to meet the demands to improve immunization services so as to reach more infants in a sustainable way, building upon the experiences of polio eradication. It includes materials adapted from polio on planning, monitoring and use of data to improve the service, that can be used at any level. Revising the manual has been a team exercise. There are contributions from a large number of experts, organizations and institutions. This new edition has seven modules. Several new vaccines that have become more readily available and used in recent years have been added. Also the section on integration with other health interventions has been expanded as exciting opportunities and experiences have become evident in the years following the previous edition. Module 1: Target diseases and vaccines Module 2: The vaccine cold chain Module 3: Ensuring safe injections Module 4: Microplanning for reaching every community Module 5: Managing an immunization session Module 6: Monitoring and surveillance Module 7: Partnering with communities.